IEIH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 Aug 2022 @ 15:53):

The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies...

Stats
Today's Volume	7 023.00
Average Volume	0.00
Market Cap	36.79M
EPS	$0.357 ( 2023-09-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.440 (1.29%)

Volume Correlation

Long: 0.15 (neutral)

Short: 0.00 (neutral)

Signal:(53.667) Neutral

iShares Evolved U.S. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

iShares Evolved U.S. Correlation - Currency/Commodity

0.36
( neutral )

0.26
( neutral )

-0.63
( weak negative )

0.43
( neutral )

0.27
( neutral )

iShares Evolved U.S. Financials

Annual	2022
Revenue:	$878.24M
Gross Profit:	$794.08M (90.42 %)
EPS:	$1.800

FY	2022
Revenue:	$878.24M
Gross Profit:	$794.08M (90.42 %)
EPS:	$1.800

Financial Reports:

No articles found.

iShares Evolved U.S. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

iShares Evolved U.S.

The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.